Breaking News

Financial Report: BASi

February 10, 2016

Service revenue down 22% in the quarter

Financial Report: BASi

4Q Revenues: $5.0 million (-23%)

4Q Loss: $721,000 (loss of $404,000 4Q14)

FY Revenues: $22.7 million (-8%)

FY Earnings: $1.1 million (loss of $1.1 million FY14)

Comments: Service revenue for the quarter decreased 22% to $3.8 million, negatively impacted by fewer bioequivalence studies, as well as fewer samples received and analyzed. Product revenue was $1.1 million, down 25% impacted by lower sales of analytical instruments relating to Culex.